Romosozumab: Bone-forming agent promising for osteoporosis patients
Romosozumab, A new bone-forming agent currently under study by Amgen Inc. and Belgium’s UCB, has shown promise in research into...
Read More
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Romosozumab, A new bone-forming agent currently under study by Amgen Inc. and Belgium’s UCB, has shown promise in research into...
Read MoreInjections of a new drug may partially relieve paralysing spinal cord injuries, based on indications from a study in rats,...
Read MoreSave the date. Spineweek 2016 will take place May 16-20th 2016 in Singapore. The event will take place at the...
Read MoreStryker Corporation's Spine Division has launched LITe® (Less Invasive Technology) TLIF Procedural Solution during the North American Spine Society's Annual Meeting...
Read MoreSIGNUS Medizintechnik, the German developer and manufacturer of spinal implants, has received FDA clearance to commercially release its Signus MOBIS ® II...
Read MoreTitan Spine, innovative spinal interbody fusion implants specialist has announced that it has received 510(k) clearance from the U.S. Food...
Read MoreMedtech, who specialise in the design, development and marketing of surgical robots has announced the CE Marking of its new...
Read MoreSSN meets Dr Paul Slosar, Chief Medical Officer at Titan Spine Tell us about your role as Chief Medical Officer...
Read MoreSpinal Surgery News online features news, opinions, events, reviews, product information and a wide range of peer-reviewed scientific material of interest to specialist spinal professionals.
The journal has several eminent editorial contributors guiding its content; and we also work closely with companies in the industry to ensure it remains useful and relevant.